Table 3:

Demographic Characteristics at Time of DXA for High-Risk Patients by Study Group

Characteristic	Physician-Managed (n = 237 DXA scansa)	Pharmacist-Managed (n = 311 DXA scansa)	p-value
Age (yrs), mean ± SD	77.06 ± 6.2	77.26 ± 7.2	0.733
Race, n (%)			0.218
Caucasian	214 (91.1)	282 (90.7)
African American	14 (6.0)	11 (3.5)
Hispanic	1 (0.4)	5 (1.6)
Height (cm), mean ± SD	159.6 ± 9.3	159.6 ± 6.9	1.000
Weight (kg), mean ± SD	66.0 ± 13.2	63.9 ± 11.8	0.051
BMD (g/cm2), mean ± SD
Lumbar spine	1.040 ± 0.170	1.026 ± 0.200	0.387
Right femoral neck	0.749 ± 0.084	0.729 ± 0.101	0.014
Left femoral neck	0.745 ± 0.084	0.722 ± 0.099	0.004
Radius	0.655 ± 0.101	0.654 ± 0.106	0.911
T-scores, mean ± SD
Lumbar spine	−1.190 ± 1.343	−1.238 ± 1.598	0.709
Right femoral neck	−2.058 ± 0.646	−2.213 ± 0.731	0.010
Left femoral neck	−2.081 ± 0.603	−2.233 ± 0.684	0.007
Radius	−2.549 ± 1.137	−2.514 ± 1.229	0.733
FRAX Scores, mean ± SD
Major osteoporotic	16.620 ± 4.316	17.446 ± 6.556	0.093
Hip fracture	4.656 ± 2.261	6.053 ± 4.543	< 0.001
Fracture historyb, n (%)	49 (20.7)	60 (19.3)	0.746
TSH (uIU/mL), mean ± SD	2.292 ± 1.515	2.309 ± 2.341	0.923
Vitamin Dc (pg/ml), mean ± SD	34.2 ± 11.8	36.8 ± 14.4	0.025
Documented ADR to antifracture therapyd, n (%)	20 (8.4)	31 (10.0)	0.557
Alcohol usee, n (%)	8 (3.4)	11 (3.5)	1.000
Current smoker, n (%)	10 (4.2)	20 (6.4)	0.344

^aUnique patients: n = 174 physician-managed group, n = 221 pharmacist-physician collaboration

^bDetermined by the patient’s response on the pre-procedure DXA scan form.

^cTotal 25-hydroxy vitamin D

^dDetermined from review of chart notes within one year of DXA and documented allergies.

^eDefined as a documented alcohol consumption of > 3 drinks per day within the patient’s social history or chart note or patient response on the pre-procedure DXA scan form.